HCP, Inc. (HCP) Shares Bought by Sumitomo Mitsui Trust Holdings Inc.
Sumitomo Mitsui Trust Holdings Inc. increased its holdings in HCP, Inc. (NYSE:HCP) by 2.4% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 1,850,958 shares of the real estate investment trust’s stock after buying an additional 44,208 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc. owned about 0.39% of HCP worth $48,717,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Mount Yale Investment Advisors LLC bought a new stake in HCP in the 2nd quarter worth about $104,000. Piedmont Investment Advisors LLC bought a new stake in HCP in the 2nd quarter worth about $142,000. Peoples Financial Services CORP. increased its holdings in HCP by 87.7% in the 3rd quarter. Peoples Financial Services CORP. now owns 6,100 shares of the real estate investment trust’s stock worth $161,000 after buying an additional 2,850 shares in the last quarter. Lourd Capital LLC bought a new stake in HCP in the 3rd quarter worth about $211,000. Finally, First Hawaiian Bank bought a new stake in HCP in the 3rd quarter worth about $215,000. Institutional investors own 89.32% of the company’s stock.
Shares of NYSE:HCP opened at $28.66 on Tuesday. The stock has a market capitalization of $13.43 billion, a price-to-earnings ratio of 14.70, a PEG ratio of 7.20 and a beta of 0.16. The company has a debt-to-equity ratio of 1.21, a quick ratio of 0.48 and a current ratio of 0.48. HCP, Inc. has a 52-week low of $21.48 and a 52-week high of $29.32.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 20th. Stockholders of record on Monday, November 5th will be given a dividend of $0.37 per share. The ex-dividend date is Friday, November 2nd. This represents a $1.48 dividend on an annualized basis and a dividend yield of 5.16%. HCP’s payout ratio is currently 75.90%.
HCP has been the topic of several research reports. ValuEngine raised HCP from a “hold” rating to a “buy” rating in a research report on Monday, November 12th. Zacks Investment Research reissued a “sell” rating on shares of HCP in a research report on Tuesday, November 13th. Royal Bank of Canada raised HCP from a “sector perform” rating to an “outperform” rating in a research report on Friday, November 2nd. Cantor Fitzgerald raised their target price on HCP from $29.00 to $30.00 and gave the stock an “overweight” rating in a research report on Thursday, November 1st. Finally, BMO Capital Markets reissued a “hold” rating and issued a $27.00 target price on shares of HCP in a research report on Wednesday, October 31st. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and six have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $26.75.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Featured Story: Cost of Debt
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.